Pension Fund Sues To Block Novartis, Alcon Deal
A $95 million pension fund based in Massachusetts has reportedly slammed a move by Swiss drugmaker Novartis AG to gain control of eye care company Alcon Inc. in a $28.1 billion...To view the full article, register now.
Already a subscriber? Click here to view full article